A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Novel Intravenous Formulation of Meloxicam (QP001) in Healthy Chinese Subjects.
Junlong MaJie HuangChan ZouQian WuJinlian XieXingfei ZhangXiaoyan YangShuang YangZiteng WuYan JiangSen YuXuqing ZhangGuo-Ping YangMingyuan LiPublished in: Drug design, development and therapy (2023)
The trial is registered at chinadrugtrials.org.cn (ChiCTR2100047884).